Exploring the Effect of Halogenation in a Series of Potent and Selective A


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
12 01 2023
Historique:
pubmed: 15 12 2022
medline: 14 1 2023
entrez: 14 12 2022
Statut: ppublish

Résumé

The modulation of the A

Identifiants

pubmed: 36517209
doi: 10.1021/acs.jmedchem.2c01768
pmc: PMC9841532
doi:

Substances chimiques

Purinergic P1 Receptor Antagonists 0
Adenosine A2 Receptor Antagonists 0
Receptor, Adenosine A2B 0
Ligands 0
Halogens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

890-912

Références

Oncotarget. 2018 Feb 6;9(17):13593-13611
pubmed: 29568380
J Mol Med (Berl). 2014 Mar;92(3):201-6
pubmed: 24362516
Immunol Lett. 2019 Jan;205:9-15
pubmed: 29702147
Int Rev Neurobiol. 2014;119:349-71
pubmed: 25175972
J Chem Theory Comput. 2021 Jul 13;17(7):4291-4300
pubmed: 34096718
Trends Pharmacol Sci. 1993 Apr;14(4):110-2
pubmed: 8516953
Trends Pharmacol Sci. 2016 Aug;37(8):625-640
pubmed: 27267697
Biosens Bioelectron. 2015 Dec 15;74:233-42
pubmed: 26143464
Pharmacol Rev. 2011 Mar;63(1):1-34
pubmed: 21303899
Immunol Cell Biol. 2017 Apr;95(4):333-339
pubmed: 28174424
J Med Chem. 2007 May 31;50(11):2732-6
pubmed: 17469811
Biochem Pharmacol. 2021 May;187:114393
pubmed: 33359363
J Immunother Cancer. 2022 May;10(5):
pubmed: 35580926
ACS Med Chem Lett. 2013 Oct 03;4(11):1031-6
pubmed: 24900602
Life Sci. 2016 Dec 1;166:92-99
pubmed: 27729268
J Med Chem. 2019 Oct 24;62(20):9315-9330
pubmed: 31557025
Curr Opin Pharmacol. 2016 Aug;29:7-16
pubmed: 27209048
J Chem Inf Model. 2019 Aug 26;59(8):3400-3412
pubmed: 31361490
Biosens Bioelectron. 2016 Mar 15;77:824-36
pubmed: 26513290
Pharmacol Ther. 2019 Jun;198:20-33
pubmed: 30677476
ACS Chem Biol. 2009 Apr 17;4(4):249-60
pubmed: 19193052
Bioinformatics. 2010 Dec 1;26(23):2988-9
pubmed: 20947523
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Assay Drug Dev Technol. 2004 Aug;2(4):363-72
pubmed: 15357917
J Control Release. 2018 Aug 10;283:135-142
pubmed: 29859955
J Med Chem. 2017 Apr 27;60(8):3372-3382
pubmed: 28368607
J Cheminform. 2019 Apr 2;11(1):26
pubmed: 30941533
J Chem Theory Comput. 2015 Jul 14;11(7):3499-509
pubmed: 26190950
BMC Genomics. 2011 Jan 07;12:14
pubmed: 21214938
Cell Death Differ. 2007 Jul;14(7):1315-23
pubmed: 17396131
J Med Chem. 2020 Nov 12;63(21):12196-12212
pubmed: 32667814
J Med Chem. 2016 Mar 10;59(5):1967-83
pubmed: 26824742
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629
pubmed: 32514148
Sci Rep. 2021 Jul 8;11(1):14171
pubmed: 34238993
J Immunother Cancer. 2019 Oct 10;7(1):257
pubmed: 31601268
Nat Rev Cancer. 2013 Dec;13(12):842-57
pubmed: 24226193
Chirality. 1999;11(8):659-62
pubmed: 10467318
CNS Neurol Disord Drug Targets. 2012 Sep;11(6):664-74
pubmed: 22963436
Cell Mol Life Sci. 2021 Apr;78(8):3957-3968
pubmed: 33580270
Cells. 2021 Oct 21;10(11):
pubmed: 34831054
Trends Immunol. 2009 Jun;30(6):263-70
pubmed: 19427267
Int J Mol Sci. 2021 Jul 19;22(14):
pubmed: 34299305
Biochim Biophys Acta. 2011 May;1808(5):1329-39
pubmed: 20546702
PLoS One. 2012;7(1):e29420
pubmed: 22242170
Methods Enzymol. 2013;529:227-40
pubmed: 24011049
J Adv Pract Oncol. 2013 Jul;4(4):263-8
pubmed: 25032007
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
J Chem Theory Comput. 2013 Feb 12;9(2):1282-93
pubmed: 26588769
Chem Rev. 2016 Jan 27;116(2):422-518
pubmed: 26756377
J Comput Chem. 2005 Dec;26(16):1752-80
pubmed: 16211539
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):382-91
pubmed: 11111832
Handb Exp Pharmacol. 2009;(193):v-vi
pubmed: 19739338
J Pharmacol Exp Ther. 2004 Jan;308(1):358-66
pubmed: 14563788
Mol Pharmacol. 1999 Oct;56(4):705-13
pubmed: 10496952
Int J Mol Sci. 2019 Oct 17;20(20):
pubmed: 31627281
J Med Chem. 2021 Jan 14;64(1):458-480
pubmed: 33372800
J Enzyme Inhib Med Chem. 2007 Oct;22(5):527-40
pubmed: 18035820
J Neurochem. 2012 Nov;123(3):373-84
pubmed: 22924752
Blood. 2013 Jul 4;122(1):9-18
pubmed: 23678003
J Med Chem. 2020 Jul 23;63(14):7721-7739
pubmed: 32573250
J Am Chem Soc. 2015 Feb 25;137(7):2695-703
pubmed: 25625324
Chem Res Toxicol. 2017 Apr 17;30(4):1046-1059
pubmed: 28256829
J Mol Graph Model. 1998 Aug-Dec;16(4-6):213-25, 261
pubmed: 10522241
Front Pharmacol. 2018 Oct 19;9:1200
pubmed: 30405415
J Med Chem. 2019 Apr 25;62(8):4032-4055
pubmed: 30835463

Auteurs

Rubén Prieto-Díaz (R)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, 75124Uppsala, Sweden.

Manuel González-Gómez (M)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Hugo Fojo-Carballo (H)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Jhonny Azuaje (J)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Abdelaziz El Maatougui (A)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Maria Majellaro (M)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

María I Loza (MI)

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

José Brea (J)

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Víctor Fernández-Dueñas (V)

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neuroscience, University of Barcelona, 08907L'Hospitalet de Llobregat, Spain.
Neuropharmacology and Pain Group, Neuroscience Program, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907L'Hospitalet de Llobregat, Spain.

M Rita Paleo (MR)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Alejandro Díaz-Holguín (A)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, 75124Uppsala, Sweden.

Beatriz Garcia-Pinel (B)

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Ana Mallo-Abreu (A)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Juan C Estévez (JC)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Antonio Andújar-Arias (A)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Xerardo García-Mera (X)

Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Iria Gomez-Tourino (I)

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Francisco Ciruela (F)

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neuroscience, University of Barcelona, 08907L'Hospitalet de Llobregat, Spain.
Neuropharmacology and Pain Group, Neuroscience Program, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907L'Hospitalet de Llobregat, Spain.

Cristian O Salas (CO)

Department of Organic Chemistry, Faculty of Chemistry and Pharmacy, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Macul, Santiago7820436, Chile.

Hugo Gutiérrez-de-Terán (H)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, 75124Uppsala, Sweden.

Eddy Sotelo (E)

Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782Santiago de Compostela, Spain.
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782Santiago de Compostela, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH